Experimental study demonstrates enhanced corneal penetration and oxygen modulation using Janus nanomotors in bacterial keratitis models, highlighting potential for non-antibiotic infection therapy.
Bacterial keratitis is a primary cause of corneal blindness, with its clinical treatment hampered by inadequate drug penetration into the deep corneal stroma and the growing emergence of antibiotic resistance. Corneal collagen cross-linking (CXL), a promising non-antibiotic strategy relying on riboflavin (RF) photosensitization and UV-induced stromal stiffening, is limited by poor bioavailability and diminished efficacy in infection-induced hypoxic microenvironments. Herein, we fabricate a self-propelled nanomotor system based on bowl-shaped Janus mesoporous SiO2 nanoparticles via ZIF-8-templated in situ masking, for active ocular drug delivery and spatiotemporal oxygen modulation. The nanomotors possess an open hemispherical architecture with abundant mesopores for efficient RF loading; catalase (CAT) is asymmetrically anchored on their outer surface via regioselective functionalization, forming a Janus structure that enables spatially controlled catalysis and directional propulsion. In antibiotic-resistant lesions, CAT catalyzes endogenous H2O2 to generate O2, driving autonomous nanomotor motion while alleviating hypoxia. This propulsion boosts trans-corneal penetration and stromal drug delivery, and sustained RF release combined with localized oxygenation restores CXL efficacy under hypoxia. This work thus presents a microenvironment-responsive nanoplatform with well-defined structure that integrates active drug delivery and oxygen modulation, overcoming key therapeutic barriers in bacterial keratitis and holding great translational potential for precision ocular nanomedicine.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: